Evaluation Of The Product Ciclo 21 Pharmacodynamics (Levonorgestrel + Ethinyl Estradiol), Marketed By Uniao Quimica Farmaceutica Nacional S/A, Compared To Nordette Product To The Lab Wyeth Pharmaceutical Industries Ltd.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ethinylestradiol/levonorgestrel (Primary)
- Indications Pregnancy
- Focus Pharmacodynamics
- 03 Mar 2016 Biomarkers information updated
- 14 Mar 2013 Planned end date changed from 1 Sep 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.
- 14 Mar 2013 Planned initiation date changed from 1 Feb 2013 to 1 May 2013 as reported by ClinicalTrials.gov.